Related Image: Sheffield Teaching Hospitals NHS Foundation Trust delivers same day patient discharge via BigHand Digital Dictation |
(Date:7/4/2009)...s can help prevent pain and injury, doctors say ,...While baby boomers are not as young as they used t...ertain precautions are in order to stay injury-fre... steps to protect themselves from injuries when ex...ican Academy of Orthopaedic Surgeons, said in a ne...
(Date:7/3/2009)... newest revolution in microbiology testing walks o...p, a less-hirsute version of the familiar woolly b...iversity School of Medicine, which is to be publis...these ruminants low-maintenance and parasite-resis...crobiology tests necessary to diagnose infectious ...
(Date:7/3/2009)...uly 3 Bertalan Mesko, medical blog...e-guide for medical professionals focusing on ho...cal conferences are expensive and patients are als... eGuide helps doctors enter a virtual realm and or... as Second Life provides opportunities for case pr...
(Date:7/3/2009)... that finding will lead to treatments, , ...rchers say they,ve found a major cellular flaw tha...er. , When caught early, lung cancer can often ...the disease is well advanced. Though doctors can s...e often springs back more virulent than ever, freq...
Breaking Medicine News(10 mins):Health News:Exercise Tips to Keep Boomers on Their Feet 2Health News:Rare sheep could be key to better diagnostic tests in developing world, says Stanford study 2Health News:Rare sheep could be key to better diagnostic tests in developing world, says Stanford study 3Health News:Cell Pathway May Be Key to Lung Cancer's Spread 2Health News:Cell Pathway May Be Key to Lung Cancer's Spread 3...ege of Medicine of Yeshiva University have managed...ease by using their previous research on tuberculo...ugust issue of Nature Methods, “should substantial...laria under control,” according to Dr. David Fidoc...
...t NHS general practioner and hospital consultants ...nce UniChem Private Limited //Company to become Al...ew of the Boots stores in London are already provi... opposition has come from the British medical asso...
...ster than he who is caught by it" ……..Homer in 'S...6th of December 2004, giant killer waves struck th...edented in both its severity and impact. These wav...Tsunami, was the most devastating that history has...
...successfully performed on an eight-month-old Egypt...tisam Ibrahim was initially evaluated by a team of...pital and was diagnosed to have complete atrio-ven...sures -- a condition wherein there are holes in th...
Other Medicine News:Health News:Malaria Truths Discovered By Einstein Researchers 2Health News:The Lurking Tsunami: Are We Ready? 2(Date:6/29/2009)... , Study in major abdominal surgery patients ac...OOD CITY, Calif., June 29 AcelRx P...lts from the second Phase 2 clinical study evaluat...il NanoTabs(TM) for the management of acute post-o...ia during hospitalization. Compared to placebo, pa...
(Date:6/28/2009)... , S. MAMEDE DO CORONADO, Portugal, June 29...t, demonstrated that add-on treatment with the nov...rbazepine acetate; ESL) resulted,in a marked and ...ong-term(1). , Results from the one-year ex...e III study were presented at the International Co...
(Date:6/26/2009)... , In the news release, "Agendia,s Breast C...rnational St. Gallen Expert Consensus Recommendati...B.V. over PR Newswire, please be advised,that the...rectly transmitted,by PR Newswire. Complete, corr...-- , Agendia,s Breast Cancer Recurrence Tes...
(Date:6/25/2009)... , NEW YORK, June 25 ... Parkinson,s Research has already funded over $1 m...kinson,s therapeutic development through its groun...ects include investigations of the safety and effi... treat Parkinson,s; characterization of a tenuous ...
Breaking Medicine Technology:AcelRx Announces Positive Phase 2 Results from a Study of ARX-01 Sufentanil NanoTabs in Treating Post-Operative Pain 2AcelRx Announces Positive Phase 2 Results from a Study of ARX-01 Sufentanil NanoTabs in Treating Post-Operative Pain 3AcelRx Announces Positive Phase 2 Results from a Study of ARX-01 Sufentanil NanoTabs in Treating Post-Operative Pain 4Data Demonstrates Long-Term Reduction In Seizure Frequency With Novel Once Daily Anti-Epileptic Zebinix(R) 2Data Demonstrates Long-Term Reduction In Seizure Frequency With Novel Once Daily Anti-Epileptic Zebinix(R) 3Data Demonstrates Long-Term Reduction In Seizure Frequency With Novel Once Daily Anti-Epileptic Zebinix(R) 4Data Demonstrates Long-Term Reduction In Seizure Frequency With Novel Once Daily Anti-Epileptic Zebinix(R) 5Data Demonstrates Long-Term Reduction In Seizure Frequency With Novel Once Daily Anti-Epileptic Zebinix(R) 6Data Demonstrates Long-Term Reduction In Seizure Frequency With Novel Once Daily Anti-Epileptic Zebinix(R) 7/C O R R E C T I O N -- Agendia B.V./ 2/C O R R E C T I O N -- Agendia B.V./ 3MJFF's Rapid Response Innovation Awards Hit Mid-2009 With Over $1 Million Funded in High-Risk/High-Reward Approaches to Parkinson's Disease 2MJFF's Rapid Response Innovation Awards Hit Mid-2009 With Over $1 Million Funded in High-Risk/High-Reward Approaches to Parkinson's Disease 3Victhom and Otto Bock sign partnership agreement to establish joint venture for Neurobionix activities 11841 1Victhom and Otto Bock sign partnership agreement to establish joint venture for Neurobionix activities 11841 2Victhom and Otto Bock sign partnership agreement to establish joint venture for Neurobionix activities 11841 3Victhom and Otto Bock sign partnership agreement to establish joint venture for Neurobionix activities 11841 4Victhom and Otto Bock sign partnership agreement to establish joint venture for Neurobionix activities 11841 5WHO Raises Swine Flu Alert 44175 1WHO Raises Swine Flu Alert 44175 2WHO Raises Swine Flu Alert 44175 3WHO Raises Swine Flu Alert 44175 4WHO Raises Swine Flu Alert 44175 5WHO Raises Swine Flu Alert 44175 6Growth in North Carolina Long Term Care Costs Outpacing the Rate of Inflation According to Annual Genworth Financial Study 44171 1Growth in North Carolina Long Term Care Costs Outpacing the Rate of Inflation According to Annual Genworth Financial Study 44171 2Growth in North Carolina Long Term Care Costs Outpacing the Rate of Inflation According to Annual Genworth Financial Study 44171 3Growth in North Carolina Long Term Care Costs Outpacing the Rate of Inflation According to Annual Genworth Financial Study 44171 4Growth in North Carolina Long Term Care Costs Outpacing the Rate of Inflation According to Annual Genworth Financial Study 44171 5Growth in Nevada Long Term Care Costs Outpacing the Rate of Inflation According to Annual Genworth Financial Study 44167 1Growth in Nevada Long Term Care Costs Outpacing the Rate of Inflation According to Annual Genworth Financial Study 44167 2Growth in Nevada Long Term Care Costs Outpacing the Rate of Inflation According to Annual Genworth Financial Study 44167 3Growth in Nevada Long Term Care Costs Outpacing the Rate of Inflation According to Annual Genworth Financial Study 44167 4...007 - Inovio Biomedical,Corporation (AMEX:INO), fo... for cancers and infectious diseases and a novel,a...announced today,that interim clinical trial result...vered by Inovio,s electroporation technology was,s...d resulted in,significant objective tumor response...
...nstrated Among Patients with,Active Disease, MOUNT...moCentryx, Inc., a clinical-stage biopharmaceutica...ommercializing,orally-administered therapeutics th...ay from the company,s Phase 2 clinical trial of,Tr...matory agent,that targets the chemokine receptor C...
Other Medicine Technology:Inovio Biomedical's DNA Delivery Technology Shows Safety and,Enhances Gene Expression & Tumor Responses in Interim Melanoma,Clinical Study Results 2Inovio Biomedical's DNA Delivery Technology Shows Safety and,Enhances Gene Expression & Tumor Responses in Interim Melanoma,Clinical Study Results 3Inovio Biomedical's DNA Delivery Technology Shows Safety and,Enhances Gene Expression & Tumor Responses in Interim Melanoma,Clinical Study Results 4Inovio Biomedical's DNA Delivery Technology Shows Safety and,Enhances Gene Expression & Tumor Responses in Interim Melanoma,Clinical Study Results 5ChemoCentryx Presents Positive Phase 2 Clinical Data for,Traficet-EN in Crohn's Disease at the Digestive Disease Week 2007,Conference 2ChemoCentryx Presents Positive Phase 2 Clinical Data for,Traficet-EN in Crohn's Disease at the Digestive Disease Week 2007,Conference 3ChemoCentryx Presents Positive Phase 2 Clinical Data for,Traficet-EN in Crohn's Disease at the Digestive Disease Week 2007,Conference 4ChemoCentryx Presents Positive Phase 2 Clinical Data for,Traficet-EN in Crohn's Disease at the Digestive Disease Week 2007,Conference 5...the power of clinical information. , ,S/5 Clinica...cal connectivity solutions that help you and your ...nt care. You will have access to essential patient...e team and specialists, independent of time and lo...
...onitoring for intermediate care., ,The S/5 FM is ...a S/5 product line., ,The S/5 FM has a modular de...ient Side Module (PSM) includes a comprehensive pa...CG, NIBP, motion-tolerant SpO 2 , 2 temperatures a...
...d comprehensive solution for advanced arrhythmia a...provides one compact, PC-based solution for both b...ts to Datex-Ohmeda Network and supports advanced a...rrhythmia Workstation detects and classifies more ...
... centralized monitoring with wireless connectivity...ure for the S/5 monitoring system that makes it po...o the S/5 Central Station via Wireless LAN technol...oviding continuous centralized surveillance within...
Medicine Products: